Janney Montgomery Scott LLC Has $407,000 Holdings in Neogen Co. (NASDAQ:NEOG)

Janney Montgomery Scott LLC lowered its position in shares of Neogen Co. (NASDAQ:NEOGGet Rating) by 27.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,914 shares of the company’s stock after selling 6,324 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Neogen were worth $407,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. GW&K Investment Management LLC acquired a new stake in shares of Neogen during the first quarter valued at approximately $27,000. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of Neogen by 87.5% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 913 shares of the company’s stock valued at $28,000 after acquiring an additional 426 shares during the period. Exchange Traded Concepts LLC acquired a new stake in shares of Neogen during the first quarter valued at approximately $34,000. JJJ Advisors Inc. raised its holdings in shares of Neogen by 71.6% during the first quarter. JJJ Advisors Inc. now owns 2,052 shares of the company’s stock valued at $64,000 after acquiring an additional 856 shares during the period. Finally, Point72 Hong Kong Ltd acquired a new stake in shares of Neogen during the first quarter valued at approximately $71,000. Institutional investors and hedge funds own 97.86% of the company’s stock.

Neogen Stock Performance

Shares of NEOG opened at $16.28 on Monday. The company’s 50 day moving average price is $14.11 and its 200 day moving average price is $20.36. Neogen Co. has a 52 week low of $10.49 and a 52 week high of $47.80. The company has a market capitalization of $1.76 billion, a PE ratio of 47.88 and a beta of 0.72.

Insider Activity at Neogen

In other Neogen news, CEO John Edward Adent bought 22,000 shares of the firm’s stock in a transaction on Wednesday, September 28th. The stock was bought at an average cost of $14.37 per share, with a total value of $316,140.00. Following the completion of the transaction, the chief executive officer now directly owns 80,103 shares of the company’s stock, valued at approximately $1,151,080.11. The purchase was disclosed in a document filed with the SEC, which is available through this link. In other Neogen news, CEO John Edward Adent bought 22,000 shares of the firm’s stock in a transaction on Wednesday, September 28th. The stock was bought at an average cost of $14.37 per share, with a total value of $316,140.00. Following the completion of the transaction, the chief executive officer now directly owns 80,103 shares of the company’s stock, valued at approximately $1,151,080.11. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, COO Douglas Edward Jones bought 7,000 shares of the firm’s stock in a transaction on Wednesday, September 28th. The stock was acquired at an average cost of $14.31 per share, with a total value of $100,170.00. Following the completion of the transaction, the chief operating officer now directly owns 9,759 shares of the company’s stock, valued at $139,651.29. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 37,100 shares of company stock valued at $526,233. Corporate insiders own 0.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. StockNews.com started coverage on shares of Neogen in a report on Wednesday, October 12th. They set a “hold” rating on the stock. Piper Sandler lowered their price objective on shares of Neogen from $20.00 to $14.00 and set a “neutral” rating on the stock in a research report on Monday, October 10th.

Neogen Company Profile

(Get Rating)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells.

See Also

Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOGGet Rating).

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.